BioCentury
ARTICLE | Company News

Anadys, Novartis deal

August 14, 2006 7:00 AM UTC

ANDS said NVS's exclusive option to license ANA380 has expired and that it will not extend the exclusivity period (see BioCentury, June 6, 2005). However, the company said it is in discussions with NV...